Dodge & Cox Amgen Inc Transaction History

Dodge & Cox

$165 Billion
Q3 2024

A detailed history of Dodge & Cox transactions in Amgen Inc stock. As of the latest transaction made, Dodge & Cox holds 14,282 shares of AMGN stock, worth $4.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,282

Previous 14,382 0.7%

Holding current value

$4.21 Million

Previous $4.49 Million 2.4%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $30,938 - $33,738	-100 Reduced 0.7%	14,282 $4.6 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $21,865 - $27,145	-100 Reduced 0.69%	14,382 $3.87 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $112,491 - $133,019	-525 Reduced 3.5%	14,482 $3.22 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $270,948 - $330,240	-1,200 Reduced 7.4%	15,007 $3.63 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $67,338 - $75,945	-300 Reduced 1.82%	16,207 $3.65 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $23,071 - $25,674	-100 Reduced 0.6%	16,507 $4.02 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $59,664 - $68,280	-300 Reduced 1.77%	16,607 $3.74 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $205,550 - $228,043	-880 Reduced 4.95%	16,907 $4.12 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $15,533 - $18,102	-70 Reduced 0.39%	17,787 $4.43 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $238,018 - $283,437	-1,100 Reduced 5.8%	17,857 $4.11 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $278,060 - $309,225	-1,185 Reduced 5.88%	18,957 $4.82 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $129,565 - $158,994	-655 Reduced 3.15%	20,142 $4.75 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $104,788 - $138,977	-575 Reduced 2.69%	20,797 $4.22 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $4,730 - $6,080	-25 Reduced 0.12%	21,372 $5.15 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $39,174 - $46,939	-225 Reduced 1.04%	21,397 $4.14 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $33,340 - $39,082	-200 Reduced 0.92%	21,622 $3.99 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $108,522 - $122,328	-600 Reduced 2.68%	21,822 $4.15 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $107,040 - $124,950	-600 Reduced 2.61%	22,422 $4.37 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $240,877 - $271,557	-1,300 Reduced 5.34%	23,022 $4.77 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $74,722 - $83,929	-450 Reduced 1.82%	24,322 $4.49 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $326,152 - $381,150	-1,925 Reduced 7.21%	24,772 $4.22 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $192,420 - $214,992	-1,140 Reduced 4.1%	26,697 $4.64 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $4.66 Million - $5.32 Million	27,837	27,837 $5.19 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account